Autoimmune priming, tissue attack and chronic inflammation - The three stages of rheumatoid arthritis

European Journal of Immunology

Volumn 44, Issue 6, 2014, Pages 1593-1599

  Holmdahl, Rikard ^a   Malmström, Vivianne ^a   Burkhardt, Harald ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Animal models; Autoimmunity; Rheumatology

Indexed keywords

AUTOANTIBODY;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CHRONIC DISEASE; CHRONIC INFLAMMATION; DISEASE COURSE; ENVIRONMENTAL FACTOR; EXPERIMENTAL STUDY; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; JOINT; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMAL MODELS; AUTOIMMUNITY; RHEUMATOLOGY;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFLAMMATION;

EID: 84901838879     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444486     Document Type: Article

References (63)

1. Stastny, P., Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N. Engl. J. Med. 1978. 298: 869-871.
2. Gregersen, P. K., Silver, J. and Winchester, R. J., The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheumatol. 1987. 30: 1205-1213.
3. Sandor, C., Stahl, E. A., Freudenberg, J., Lee, H.-S., Jia, X., Alfredsson, L., Padyukov, L. et al., Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet. 2012: 1-8.
4. Gregersen, P. K. and Olsson, L. M., Recent advances in the genetics of autoimmune disease. Annu. Rev. Immunol. 2009. 27: 363-391.
5. Okada, Y., Wu, D., Trynka, G., Raj, T., Terao, C., Ikari, K., Kochi, Y. et al., Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2014. 506: 376-381.
6. Aho, K., Palosuo, T., Raunio, V., Puska, P., Aromaa, A. and Salonen, J. T., When does rheumatoid disease start? Arthritis Rheumatol. 1985. 28: 485-489.
7. Carayannopoulos, M. O., Potter, K. N., Li, Y., Natvig, J. B. and Capra, J. D., Evidence that human immunoglobulin M rheumatoid factors can Be derived from the natural autoantibody pool and undergo an antigen driven immune response in which somatically mutated rheumatoid factors have lower affinities for immunoglobulin G Fc than their germline counterparts. Scand. J. Immunol. 2000. 51: 327-336.
8. Bonagura, V. R., Agostino, N., Børretzen, M., Thompson, K. M., Natvig, J. B. and Morrison, S. L., Mapping IgG epitopes bound by rheumatoid factors from immunized controls identifies disease-specific rheumatoid factors produced by patients with rheumatoid arthritis. J. Immunol. 1998. 160: 2496-2505.
9. Randen, I., Thompson, K. M., Pascual, V., Victor, K., Beale, D., Coadwell, J., Førre, O. et al., Rheumatoid factor V genes from patients with rheumatoid arthritis are diverse and show evidence of an antigen-driven response. Immunol. Rev. 1992. 128: 49-71.
10. Duquerroy, S., Stura, E. A., Bressanelli, S., Fabiane, S. M., Vaney, M. C., Beale, D., Hamon, M. et al., Crystal structure of a human autoimmune complex between IgM rheumatoid factor RF61 and IgG1 Fc reveals a novel epitope and evidence for affinity maturation. J. Mol. Biol. 2007. 368: 1321-1331.
11. Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B. and van Venrooij, W. J., Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 1998. 101: 273-281.
12. Girbal-Neuhauser, E., Durieux, J. J., Arnaud, M., Dalbon, P., Sebbag, M., Vincent, C., Simon, M. et al., The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J. Immunol. 1999. 162: 585-594.
13. Rantapää-Dahlqvist, S., de Jong, B. A. W., Berglin, E., Hallmans, G., Wadell, G., Stenlund, H., Sundin, U. et al., Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheumatol. 2003. 48: 2741-2749.
14. Shi, J., van de Stadt, L. A., Levarht, E. W. N., Huizinga, T. W. J., Hamann, D., van Schaardenburg, D., Toes, R. E. M. et al., Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis. Ann. Rheum. Dis. 2014. 73: 780-783.
15. Haj Hensvold, A., Magnusson, P. K. E., Joshua, V., Hansson, M., Israelsson, L., Ferreira, R., Jakobsson, P.-J. et al., Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins. Ann. Rheum. Dis. 2013. In press. DOI: 10.1136/annrheumdis-2013-203947.
16. Mahdi, H., Fisher, B. A., Källberg, H., Plant, D., Malmström, V., Rönnelid, J., Charles, P. et al., Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat. Genet. 2009. 41: 1319-1324.
17. Suwannalai, P., van de Stadt, L. A., Radner, H., Steiner, G., El-Gabalawy, H. S., Zijde, C. M. J.-V. D., van Tol, M. J. et al., Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheumatol. 2012. 64: 1323-1328.
18. Amara, K., Steen, J., Murray, F., Morbach, H., Fernandez-Rodriguez, B. M., Joshua, V., Engström, M. et al., Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J. Exp. Med. 2013. 210: 445-455.
19. Suwannalai, P., Scherer, H. U., van der Woude, D., Ioan-Facsinay, A., Jol-van der Zijde, C. M., van Tol, M. J. D., Drijfhout, J. W. et al., Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens. Ann. Rheum. Dis. 2011. 70: 373-379.
20. Holmdahl, R., Andersson, M., Goldschmidt, T. J., Gustafsson, K., Jansson, L. and Mo, J. A., Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol. Rev. 1990. 118: 193-232.
21. Rintisch, C., Ameri, J., Olofsson, P., Luthman, H. and Holmdahl, R., Positional cloning of the Igl genes controlling rheumatoid factor production and allergic bronchitis in rats. Proc. Natl. Acad. Sci. U.S.A. 2008. 105: 14005-14010.
22. Sakaguchi, N., Takahashi, T., Hata, H., Nomura, T., Tagami, T., Yamazaki, S., Sakihama, T. et al., Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003. 426: 454-460.
23. Mo, J. A., Bona, C. A. and Holmdahl, R., Variable region gene selection of immunoglobulin G-expressing B cells with specificity for a defined epitope on type II collagen. Eur. J. Immunol. 1993. 23: 2503-2510.
24. Dobritzsch, D., Lindh, I., Uysal, H., Nandakumar, K. S., Burkhardt, H., Schneider, G. and Holmdahl, R., Crystal structure of an arthritogenic anticollagen immune complex. Arthritis Rheumatol. 2011. 63: 3740-3748.
25. Raposo, B., Dobritzsch, D., Ge, C., Ekman, D., Xu, B., Lindh, I., Förster, M. et al., Epitope-specific antibody response is controlled by immunoglobulin VH polymorphisms. J. Exp. Med. 2014. 211: 405-411.
26. Scally, S. W., Petersen, J., Law, S. C., Dudek, N. L., Nel, H. J., Loh, K. L., Wijeyewickrema, L. C. et al., A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J. Exp. Med. 2013. 210: 2569-2582.
27. Anders, A.-K, Call, M. J., Schulze, M.-S. E. D., Fowler, K. D., Schubert, D. A., Seth, N. P., Sundberg, E. J. et al., HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide. Nat. Immunol. 2011. 12: 54-61.
28. Corper, A. L., Stratmann, T., Apostolopoulos, V., Scott, C. A., Garcia, K. C., Kang, A. S., Wilson, I. A. et al., A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 2000. 288: 505-511.
29. Santamaria, P., The long and winding road to understanding and conquering type 1 diabetes. Immunity 2010. 32: 437-445.
30. Holmdahl, R., Lorentzen, J. C., Lu, S., Olofsson, P., Wester, L., Holmberg, J., Pettersson, U., Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol. Rev. 2001. 184: 184-202.
31. Bäcklund, J., Carlsen, S., Höger, T., Holm, B., Fugger, L., Kihlberg, J., Burkhardt, H. et al., Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 2002. 99: 9960-9965.
32. Molberg, O., Mcadam, S. N., Körner, R., Quarsten, H., Kristiansen, C., Madsen, L., Fugger, L. et al., Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat. Med. 1998. 4: 713-717.
33. Lundberg, K., Kinloch, A., Fisher, B. A., Wegner, N., Wait, R., Charles, P., Mikuls, T. R. et al., Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheumatol. 2008. 58: 3009-3019.
34. + T Cell Autoimmunity to Hypocretin/Orexin and Cross-Reactivity to a 2009 H1N1 Influenza A Epitope in Narcolepsy. Sci. Transl. Med. 2013. 5: 216ra176.
35. Sverdrup, B., Källberg, H., Bengtsson, C., Lundberg, I., Padyukov, L., Alfredsson, L., Klareskog, L. et al., Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study. Arthritis Res. Ther. 2005. 7: R1296-R1303.
36. Newkirk, M. M., Mitchell, S., Procino, M., Li, Z., Cosio, M., Mazur, W., Kinnula, V. L. et al., Chronic smoke exposure induces rheumatoid factor and anti-heat shock protein 70 autoantibodies in susceptible mice and humans with lung disease. Eur. J. Immunol. 2012. 42: 1051-1061.
37. Wu, H.-J., Ivanov, I. I., Darce, J., Hattori, K., Shima, T., Umesaki, Y., Littman, D. R. et al., Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity. 2010. 32: 815-827.
38. Yoshitomi, H., Sakaguchi, N., Kobayashi, K., Brown, G. D., Tagami, T., Sakihama, T., Hirota, K. et al., A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J. Exp. Med. 2005. 201: 949-960.
39. van Baarsen, L. G. M., de Hair, M. J. H., Ramwadhdoebe, T. H., Zijlstra, I. J. A. J., Maas, M., Gerlag, D. M. and Tak, P. P., The cellular composition of lymph nodes in the earliest phase of inflammatory arthritis. Ann. Rheum. Dis. 2013. 72: 1420-1424.
40. de Hair, M. J. H., Zijlstra, I. A. J., Boumans, M. J. H., van de Sande, M. G. H., Maas, M., Gerlag, D. M. and Tak, P. P., Hunting for the pathogenesis of rheumatoid arthritis: core-needle biopsy of inguinal lymph nodes as a new research tool. Ann. Rheum. Dis. 2012. 71: 1911-1912.
41. Kleyer, A., Finzel, S., Rech, J., Manger, B., Krieter, M., Faustini, F., Araujo, E. et al., Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann. Rheum. Dis. 2014. 73: 854-860.
42. Caulfield, J. P., Hein, A., Dynesius-Trentham, R. and Trentham, D. E., Morphologic demonstration of two stages in the development of type II collagen-induced arthritis. Lab. Invest. 1982. 46: 321-343.
43. Wing, K. and Sakaguchi, S., Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 2010. 11: 7-13.
44. Dzhambazov, B., Nandakumar, K. S., Kihlberg, J., Fugger, L., Holmdahl, R. and Vestberg, M., Therapeutic vaccination of active arthritis with a glycosylated collagen type II peptide in complex with MHC class II molecules. J. Immunol. 2006. 176: 1525-1533.
45. Myers, L. K., Tang, B., Brand, D. D., Rosloniec, E. F., Stuart, J. M. and Kang, A. H., Efficacy of modified recombinant type II collagen in modulating autoimmune arthritis. Arthritis Rheumatol. 2004. 50: 3004-3011.
46. Bas, D. B., Su, J., Sandor, K., Agalave, N. M., Pettersson, J., Codeluppi, S., Baharpoor, A. et al., Collagen antibody-induced arthritis evokes persistent pain with spinal glial involvement and transient prostaglandin dependency. Arthritis Rheum. 2012. 64: 3886-3896.
47. Nandakumar, K. S., Bajtner, E., Hill, L., Böhm, B., Rowley, M. J., Burkhardt, H. and Holmdahl, R., Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammation. Arthritis Rheumatol. 2008. 58: 184-196.
48. Brink, M., Hansson, M., Mathsson, L., Jakobsson, P.-J, Holmdahl, R., Hallmans, G., Stenlund, H. et al., Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis. Arthritis Rheum. 2013. 65: 899-910.
49. Matsumoto, I., Staub, A., Benoist, C. and Mathis, D., Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 1999. 286: 1732-1735.
50. Burkhardt, H., Koller, T., Engström, A., Nandakumar, K. S., Turnay, J., Kraetsch, H. G., Kalden, J. R. et al., Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Arthritis Rheumatol. 2002. 46: 2339-2348.
51. Haag, S., Schneider, N., Mason, D. E., Tuncel, J., Andersson, I. E., Peters, E. C., Burkhardt, H. et al., Mass spectrometric analysis of citrullinated type II collagen reveals new citrulline-specific autoantibodies, which bind to human arthritic cartilage. Arthritis Rheumatol. 2014. DOI: 10.1002/art.38383.
52. Uysal, H., Bockermann, R., Nandakumar, K. S., Sehnert, B., Bajtner, E., Engström, A., Serre, G. et al., Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J. Exp. Med. 2009. 206: 449-462.
53. Li, J., Guo, Y., Holmdahl, R. and Ny, T., Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models. Arthritis Rheumatol. 2005. 52: 2541-2548.
54. Holmberg, J., Tuncel, J., Yamada, H., Lu, S., Olofsson, P. and Holmdahl, R., Pristane, a non-antigenic adjuvant, induces MHC class II-restricted, arthritogenic T cells in the rat. J. Immunol. 2006. 176: 1172-1179.
55. Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D. and Kollias, G., Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 1991. 10: 4025-4031.
56. Edwards, J. C. and Cambridge, G., Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology (Oxford) 2001. 40: 205-211.
57. Genovese, M. C., Becker, J.-C., Schiff, M., Luggen, M., Sherrer, Y., Kremer, J., Birbara, C. et al., Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. N. Engl. J. Med. 2005. 353: 1114-1123.
58. Holmdahl, R., Jansson, L., Larsson, E., Rubin, K. and Klareskog, L., Homologous type II collagen induces chronic and progressive arthritis in mice. Arthritis Rheumatol. 1986. 29: 106-113.
59. Tuncel, J., Haag, S., Carlsen, S., Yau, A. C. Y., Lu, S., Burkhardt, H. and Holmdahl, R., Class II major histocompatibility complex-associated response to type XI collagen regulates the development of chronic arthritis in rats. Arthritis Rheum. 2012. 64: 2537-2547.
60. Hultqvist, M., Olofsson, P., Holmberg, J., Bäckström, B. T., Tordsson, J. and Holmdahl, R., Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc. Natl. Acad. Sci. U.S.A. 2004. 101: 12646-12651.
61. Goldschmidt, T. J. and Holmdahl, R., Anti-T cell receptor antibody treatment of rats with established autologous collagen-induced arthritis: suppression of arthritis without reduction of anti-type II collagen autoantibody levels. Eur. J. Immunol. 1991. 21: 1327-1330.
62. Kontoyiannis, D., Pasparakis, M., Pizarro, T. T., Cominelli, F. and Kollias, G., Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999. 10: 387-398.
63. Neidhart, M., Seemayer, C. A., Hummel, K. M., Michel, B. A., Gay, R. E. and Gay, S., Functional characterization of adherent synovial fluid cells in rheumatoid arthritis: destructive potential in vitro and in vivo. Arthritis Rheumatol. 2003. 48: 1873-1880.